Clinical Trial Update: Agnostic Therapy in Rare Solid Tumors [Phase 2]

View source ↗

Summary

A Phase 2 trial of an agnostic therapy for multiple rare solid tumors is currently recruiting. The study lists a broad set of tumor types across various organs,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma
• Cholangiocarcinoma
• Neuroendocrine Tumors
• Osteosarcoma
• Ovarian Epithelial Cancer
• Parathyroid Carcinoma
• Soft Tissue Sarcoma
• Urachal Cancer

Snippet

Sponsor: Instituto do Cancer do Estado de São Paulo | Conditions: Urachal Cancer, Parathyroid Carcinoma | Phase 2 | Status: RECRUITING